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doi:10.1016/S1078-5884(07)00166-9, available online at http://www.sciencedirect.com onSelected Abstracts from the May Issue of the Journal of Vascular Surgery*Subclinical embolization after carotid artery stenting: New lesions on
diffusion-weighted magnetic resonance imaging occur postprocedure
J.H. Rapp, L. Wakil, R. Sawhney, X.M. Pan, M.A. Yenari, C. Glastonbury,
S. Coogan and M. Wintermark
Objectives. The reported rate of subclinical brain injury after carotid artery
stenting (CAS) seen on diffusion-weighted magnetic resonance imaging
(DWI) varies from 10% to>40%. Data from transcranial Doppler after CAS in-
dicate that embolization may continue for several days, suggesting that that at
least some lesions seen on DWI occur postprocedure. Because DWI lesions
appear1 hour of embolization, we used DWI to prospectively study patients
before CAS, 1 hour after, and 48 hours after CAS to answer this question.
Methods. The study participants were 48 male patients aged 59 to 83. All pa-
tients were examined by a neurologist before and after the procedure and had
DWI preprocedure and 48 hours postprocedure. In addition, 23 patients had
a DWI 1 hour post-CAS. Magnetic resonance imaging exams, including axial
and coronal DWI and fluid-attenuated inversion recovery images, were read
by two neuroradiologists blinded to the study timing. The embolic protection
device was obtained from all patients, washed, and the contents examined
under a digital microscope for fragments 60 mm.
Results. There were two periprocedural strokes and one transient ischemic
attack (TIA), but no strokes or TIAs occurred during follow-up. In the 23 pa-
tients imaged 1 hour postprocedure, new lesions were found in two (9%), and
18 (78%) had new lesions at 48 hours (P< .001). For the entire study group,
the incidence of new lesions at 48 hours was 67% (36/54). The median num-
ber of DWI lesions was four (range, 1 to 17). Every protection device exam-
ined had atherosclerotic debris, with a mean of 135 73 fragments (range,
18 to 310) sized >60 mm and a mean of eight fragments (range, 2 to 21) sized
>500 mm. Findings on postprocedure DWI did not correlate with the degree
of stenosis, size of angioplasty balloon, or number of inflations, nor with the
number or size of fragments retrieved from the protection device.
Conclusions. CAS can be performed with a very low incidence of clinically
evident neurologic events; however, it is associated with embolization during
and after the procedure. Protection devices effectively prevent clinical and
subclinical events during the procedure. Significant embolization continues
for at least 48 hours postprocedure, causing lesions on DWI when there is
no mechanism for cerebral protection. These data correlate with transcranial
Doppler reports of continued embolization after CAS and indicate that DWI
should be done as late as possible to accurately assess the rate of subclinical
brain injury with CAS procedures.
The impact of increasing age on anatomic factors affecting carotid
angioplasty and stenting
R.C. Lam, S.C. Lin, B. DeRubertis, R. Hynecek, K.C. Kent and P.L. Faries
Purpose. Current evaluations of carotid artery angioplasty and stenting (CAS)
have suggested equivalency compared with carotid endarterectomy (CEA).
However, the incidence of stroke and death with CASmay be higher in elderly
patients. We assessed the anatomic characteristics of patients undergoing CAS
and compared thembased on age older or younger than 80 years. The impact of
age on the incidence of postoperative complications was also determined.
Methods. From February 2003 to August 2005, 135 CAS procedures were per-
formed in 133 patients. Digital subtraction angiograms for each patient were
evaluated by two independent observers blinded to patient identifiers. Ana-
tomic characteristics that impact the performance of CAS were assessed as ei-
ther favorable or unfavorable. These included aortic arch elongation, arch
calcification, arch vessel origin stenosis, common and internal carotid artery
tortuosity, and treated lesion stenosis, calcification, and length. Postoperative
events were defined as myocardial infarction, stroke, and death. Fisher’s ex-
act test and c2 tests were used to determine statistical significance (P< .05).
Results. Of the 133 patients treated, 87 (65%) were men and 46 (35%) were
women; and 37 (28%) were 80 years of age. The cohort 80 years old had
an increased incidence of unfavorable arch elongation (P¼ .008), arch
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1078e5884/000638+ 03 $32.00/0  2007 Published by Elsevier Ltd.calcification (P¼ .003), common carotid or innominate artery origin stenosis
(P¼ .006), common carotid artery tortuosity (P¼ .0009), internal carotid artery
tortuosity (P¼ .019), and treated lesion stenosis (P¼ .007). No significant dif-
ference was found for treated lesion calcification or length. Perioperative ce-
rebral vascular accidents occurred in four patients (3.0%, 3 with no residual
deficit, 1 with residual deficit), myocardial infarction in three (2.2%), and one
patient (0.8%) died secondary to a hemorrhagic stroke. The combined stroke,
myocardial infarction, and death rate for the entire population was 3.7%. The
rate was significantly increased in patients aged 80 years old (10.8%) com-
pared with those aged <80 years old (1%, P¼ .012).
Conclusions. Elderly patients, defined as those aged >80 years, have a higher
incidence of anatomy that increases the technical difficulty of performing
CAS. This increase in unfavorable anatomy may be associated with compli-
cations during CAS. Although the small number of perioperative events
does not allow for determination of a direct relationship with specific ana-
tomic characteristics, the presence of unfavorable anatomy does warrant se-
rious consideration during evaluation for CAS in elderly patients.
Five-year report of a multicenter controlled clinical trial of open versus
endovascular treatment of abdominal aortic aneurysms
B.G. Peterson, J.S. Matsumura, D.C. Brewster and M.S. Makaroun, for the
Excluder Bifurcated Endoprosthesis Investigators
Objective. Compare long-term results of endovascular treatment and
standard open repair of abdominal aortic aneurysms in a multicenter,
concurrent-controlled trial.
Methods. 334 subjects were treated with standard open repair (control, n¼ 99)
or the original EXCLUDERBifurcated Endoprosthesis (test, n¼ 235). Five-year
clinical evaluations and corelab radiographic results are analyzed.
Results. Overall and aneurysm-related survival are similar. There have been
ten open conversions, most frequently for enlarging sacs without endoleak.
Two patients died after conversion. Including reinterventions and complica-
tions of reinterventions as adverse events, there is significant, persistent long-
term reduction in major adverse events. At 5 years, corelab reported 0% limb
narrowing, 0% trunk migration, 0% component (contralateral leg, aortic ex-
tender, and iliac extender) migration, 0% fracture, endoleak in 3% (2 type
II/68), and aneurysm growth (>5 mm compared to baseline) in 38% (30/
78) of the test group. There are no aneurysm ruptures in either test or control
group.
Conclusions. After 5 years follow-up, endovascular repair is a safer and effec-
tive treatment compared with open surgical repair for abdominal aortic aneu-
rysms. Major adverse events are less frequent with the endograft despite the
need for late reinterventions. Aneurysm expansion is observed in nearly two-
fifths of patients but is not associated with endoleak or aneurysm rupture.
Multicenter clinical trials are evaluating a newer version of this device de-
signed to avoid this high rate of sac expansion.
Patterns of aortic involvement in Takayasu arteritis and its clinical
implications: Evaluation with spiral CT angiography
J.W. Chung, H.-C. Kim, Y.H. Choi, S.J. Kim, W. Lee and J.H. Park
Objective. Although the luminal changes of Takayasu arteritis are well de-
picted with conventional angiography, its mural changes can be best evalu-
ated with spiral CT angiography. Here, the authors investigated the
patterns of aortic involvement in Takayasu arteritis by using CT angiography.
Methods. CT angiography was performed from the carotid bifurcation to the
iliac bifurcation in a consecutive 85 patients (M:F¼ 10:75, mean age: 37 years)
with Takayasu arteritis. Two radiologists interpreted axial images and three-
dimensional reconstructed images by consensus with respect to disease ex-
tent, lesion continuity, and disease activity based on mural and luminal
changes on CT angiography.
Results. Eighty-one (95%) patients had aortic involvement with or without
aortic branch involvement, and the other four (5%) patients had only aortic
branch involvement. In terms of aortic branches, the left common carotid4 April 2007  638/640
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639Abstractsartery (77%) and the left subclavian artery (76%) were most commonly in-
volved. Extent of disease involvement assessed by mural change was wider
than that assessed by luminal change in 52 (61%) patients. Although arterial
involvement was contiguous in 69 (81%) patients, skipped lesions were iden-
tified in 16 (19%) patients. An analysis of mural findings revealed the coexis-
tence of active and inactive lesions in nine (11%) patients.
Conclusions. Aortic involvement in Takayasu arteritis can occur from the aor-
tic root to below the iliac bifurcation, and isolated branch vessel involvement
is also possible. In most patients, aortic involvement occurs in a contiguous,
synchronous fashion. However, skipped involvement and the coexistence of
active and inactive lesions also occur.
Primary revision of mid-vein stenoses in venous bypass conduits:
Venous patch versus interposition vein
P. Kreienberg, M. Cheema, B.B. Chang, P.S.K. Paty, S.P. Roddy and R.C. III
Darling
Purpose. Patients after infrainguinal vein bypasses are a group at risk of graft
stenosis and occlusion. Revision of failing grafts has been shown to signi-
ficantly improve bypass patency and limb salvage. Options for surgical
revision of mid bypass stenosis includes either patch angioplasty (PA) or
interposition grafting (IG). We reviewed our experience with surgical revision
of vein bypass stenosis.
Methods. From April 1968 to March 2006, 7557 autogenous vein bypasses
were performed at Albany Medical Center and its affiliated institutions, of
these 316 required single or multiple revision of vein grafts with patch angio-
plasty or interposition vein grafting. Excluded were proximal and distal anas-
tomotic revisions. Only 235 bypasses had single revisions as either patch
angioplasty (n¼ 108) or interposition grafting (n¼ 127) and are the focus of
this review. The initial bypass revisions in these two groups are analyzed
for indications, clinical parameters, operative strategies, and long-term pa-
tencies and clinical outcomes.
Results. There were no significant differences in mean age, gender, or fre-
quency of comorbid conditions (coronary artery disease, pulmonary disease,
hypertension, and diabetes) between the two patient groups. Secondary pa-
tency of patch angioplasty revision at 5 years was 79%. Patencies for interpo-
sition grafting revision at 5 years were equivalent to patch angioplasty group
at 75%. When bypasses were evaluated on the basis of initial reconstructions
(ie, in situ vs excised vein bypass), the results showed that in situ bypasses
that required initial revision had similar 5-year patencies when interposition
grafting was used as the first revision strategy vs patch angioplasty (80% vs
73%). Excised vein bypasses had similar patency when patch was their first
revision strategy vs interposition grafting (4 year secondary patency 92%
vs 75% respectively).
Conclusion. Autogenous vein bypasses are at risk for developing significant
stenosis and occlusion with time. Bypass stenosis that develops in the main
body of the graft can be effectively repaired using either patch angioplasty
or interposition grafting. Depending on the host of other factors, such as
availability of autogenous venous conduit, location of stenosis, accessibility
for operative repair, and the patient’s anatomic characteristics, either opera-
tive strategy is effective in prolonging the patency of the bypass.
The effect of intensified lipid-lowering therapy on long-term prognosis in
patients with peripheral arterial disease
H.H.H. Feringa, S.E. Karagiannis, V.H. van Waning, E. Boersma,
O. Schouten, J.J. Bax and D. Poldermans
Background. The 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibi-
tors (statins) are associated with improved outcome in patients with periph-
eral arterial disease. Statins may also have beneficial properties beyond their
lipid-lowering effect.
Methods. A prospective, observational cohort study was conducted at a uni-
versity hospital from 1990 to 2005 to examine whether higher doses of statins
and lower low-density lipoprotein (LDL) cholesterol levels are both indepen-
dently associated with improved outcome in peripheral arterial disease. En-
rolled were 1374 consecutive patients (age, 6110 years, 73% male) with
peripheral arterial disease (ankle-brachial index 0.90). They were screened
for clinical risk factors, statin therapy, and LDL cholesterol levels. SerialLDL cholesterol levels were measured at 6 months and yearly after enroll-
ment. The mean follow-up time was 6.4 3.6 years, and no patients were
lost to follow-up. The primary end points were all-cause and cardiac mortal-
ity. The secondary end point was the progression to kidney failure.
Results. Overall mortality, cardiac death, and progression to kidney failure
occurred in 29%, 20%, and 5% of patients, respectively. Multivariate analysis
revealed that higher doses of statins (per 10% increase) and lower 6-month
LDL cholesterol levels (per 10 mg/dL decrease) were both independently as-
sociated with lower all-cause mortality (hazard ratio [HR], 0.71; 95% confi-
dence interval [CI], 0.62 to 0.80; and HR, 0.96; 95% CI, 0.93 to 0.98,
respectively) and cardiac death (HR, 0.76; 95% CI, 0.67 to 0.86; and HR,
0.95; 95% CI, 0.92 to 0.98, respectively). Higher high-density lipoprotein cho-
lesterol levels also correlated significantly with lower all-cause and cardiac
mortality. Higher doses of statins (per 10% increase) were associated with
less progression to kidney failure (HR, 0.69; 95% CI, 0.54 to 0.89).
Conclusions. Higher doses of statins and lower LDL cholesterol levels are
both independently associated with improved outcome in patients with
peripheral arterial disease. These results support the view that statins have
beneficial effects beyond their lipid-lowering properties and should be
considered in all patients with PAD, irrespective of LDL cholesterol levels.
Hospital specific aspects predominantly determine primary failure of
hemodialysis arteriovenous fistulas
H.J.T.A.M. Huijbregts, M.L. Bots, F.L. Moll and P.J. Blankestijn, on behalf of
the CIMINO members
Background. Primary failure of the arteriovenous fistula (AVF) is a major
problem affecting native hemodialysis access use. A multicenter guideline
implementation program, Care Improvement by Multidisciplinary approach
for Increase of Native vascular access Obtainment (CIMINO), was designed
to identify modifiable and nonmodifiable factors involved in the early func-
tionality of the AVF.
Methods. Physicians and dialysis staff in 11 centers in the Netherlands
(N¼ 1092 prevalent vascular accesses) were strongly and repeatedly advised
to adhere to current guidelines. It was advised to always perform a standard
preoperative duplex examination and physicians were encouraged to attempt
salvaging procedures for failing and failed fistulae. Specially appointed ac-
cess nurses prospectively registered all created vascular accesses in an
internet-linked database. Primary failure (PF) was defined as a complication
of the AVF before the first successful cannulation for hemodialysis treatment.
Modifiable and nonmodifiable factors were related to risk of primary failure
using logistic regression models. We restricted the analyses to the first AVF of
each patient that was placed during the observation period.
Results. Between May 2004 and May 2006, an AVF was created in 395
patients. Primary failure occurred in one third (131 cases). Factors related
to an increased risk of primary failure were female gender (odds ratio
(OR): 1.73, 95% confidence interval (CI): 1.01-2.94), renal replacement therapy
prior to AVF placement (OR: 1.19 per year on RRT, CI: 1.05-1.34), diabetes
mellitus (OR: 3.08, CI: 1.53-6.20), and AVF placement at the wrist (compared
with elbow) (OR: 1.86, CI: 1.03-3.36). Primary failure rate among the partici-
pating centers varied from 8% to 50%. Compared to the two centers with the
lowest primary failure rates, six centers had a significantly higher primary
failure rate. Adjustment for risk factors and surgery-related factors did not
materially change the center-related findings.
Conclusion. In conclusion, we have identified location of AVF placement as
a modifiable factor influencing primary failure risk. More importantly, this
study shows that the probability of primary failure is strongly related to
the center of access creation, suggesting an important role for the vascular
surgeon’s skills and decisions.
The utility of the venous clinical severity score in 682 limbs treated by
radiofrequency saphenous vein ablation
M.A. Vasquez, J. Wang, M. Mahathanaruk, G. Buczkowski, E. Sprehe and
H.H. Dosluoglu
Objectives. The goal of endovenous ablation is to reduce the symptoms
associated with chronic venous insufficiency. This prospective study was de-
signed to apply the venous clinical severity score to limbs before and after
640 Abstractsendovenous saphenous vein radiofrequency ablation and to identify risk fac-
tors associated with treatment failure.
Methods. Between September 2003 and March 2005, 499 patients underwent
682 saphenous vein radiofrequency ablation procedures. Preoperative venous
clinical severity scores were documented. Follow-up clinical and duplex ex-
aminations were performed at 4 days, 4 weeks, and 4 months after saphenous
vein radiofrequency ablation and at 6 months thereafter. Venous clinical se-
verity scoring was repeated at follow-up visits, and patients were asked to
evaluate their level of satisfaction with the procedure.
Results. The mean standard deviation age of the patients was 53.5 13.3
years (range, 28 to 86 years), and 68% were women. Pretreatment CEAP clin-
ical class C3/C4 comprised 80% of limbs (520/682). Preoperative, 4-day,
4-week, and 4-month venous clinical severity scores were, respectively,
8.8 3.7 in 648 limbs, 5.2 3.0 in 629, 4.1 2.4 in 530, and 3.3 1.6 in 479
limbs. Saphenous vein radiofrequency ablation significantly reduced pain re-
lated to lower extremity venous disease from 95.7% to 15.2% (P< .0001) andEur J Vasc Endovasc Surg Vol 33, May 2007edema from 92.4% to 17.0% (P< .0001). Before treatment, venous stasis ulcers
were present in 52 limbs and healed at a rate of 86%. Complications in
633 limbs at last follow-up included superficial thrombophlebitis in 12.0%,
paresthesia in 0.3%, and nonocclusive thrombus extension in 0.2%. No skin
thermal injury was observed. Fewer than 2% of patients reported dissatisfac-
tion with their procedural outcome. Age (relative risk, 0.98; P¼ .06), female
sex (relative risk, 0.19; P< .0001), and tumescent volume >250 mL (relative
risk, 0.59; P¼ .06) were associated with higher rates of occlusion. The overall
occlusion rate was 87.1%.
Conclusions. As determined by the venous clinical severity score, treatment
of saphenous vein reflux with endovenous radiofrequency ablation results
in the clinical improvement of symptoms and aids in the healing of venous
ulcers. Age, female sex, and tumescent volume are associated with high suc-
cess rates of occlusion. We found the venous clinical severity score to be an
excellent stand-alone tool for assessing outcomes after saphenous vein radio-
frequency ablation.
